File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: The proliferation of stem cell therapies in post-Mao China: Problematizing ethical regulation

TitleThe proliferation of stem cell therapies in post-Mao China: Problematizing ethical regulation
Authors
Keywordsgovernance
biopolitics
China
ethics
stem cell science
Issue Date2011
Citation
New Genetics and Society, 2011, v. 30, n. 2, p. 141-153 How to Cite?
AbstractThousands of foreign patients have sought experimental stem cell therapies in China since 2001. Despite critical scrutiny from scientific experts and tightening guidelines on the conduct of translational medicine, stem cell clinics have continued to proliferate in contemporary China. This article delves beyond regulatory exteriors to provide an ethnographic account of why unauthorized stem cell clinics targeting foreign clients have flourished under "socialism with Chinese characteristics." As the former emphasis on preventive care during Mao's era of collectivism has given way to a market-driven pursuit of high-tech interventions, changes in the political economy of healthcare have transformed China's urban medical system into a laboratory for entrepreneurial tactics. This article traces how medical entrepreneurs operate within and beyond the socialist market economy by co-opting public hospital facilities for private gain and capitalizing on the hope and hype over stem cell research to promote dubious procedures. Rather than producing biopolitical modes of governance, formal regulation in China often invites enterprising tactics and hybrid practices that ultimately remake the boundaries between public and private, as well as ethical and unethical. © 2011 Taylor & Francis.
Persistent Identifierhttp://hdl.handle.net/10722/260261
ISSN
2023 Impact Factor: 1.3
2023 SCImago Journal Rankings: 0.415
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorSong, Priscilla-
dc.date.accessioned2018-09-12T02:00:56Z-
dc.date.available2018-09-12T02:00:56Z-
dc.date.issued2011-
dc.identifier.citationNew Genetics and Society, 2011, v. 30, n. 2, p. 141-153-
dc.identifier.issn1463-6778-
dc.identifier.urihttp://hdl.handle.net/10722/260261-
dc.description.abstractThousands of foreign patients have sought experimental stem cell therapies in China since 2001. Despite critical scrutiny from scientific experts and tightening guidelines on the conduct of translational medicine, stem cell clinics have continued to proliferate in contemporary China. This article delves beyond regulatory exteriors to provide an ethnographic account of why unauthorized stem cell clinics targeting foreign clients have flourished under "socialism with Chinese characteristics." As the former emphasis on preventive care during Mao's era of collectivism has given way to a market-driven pursuit of high-tech interventions, changes in the political economy of healthcare have transformed China's urban medical system into a laboratory for entrepreneurial tactics. This article traces how medical entrepreneurs operate within and beyond the socialist market economy by co-opting public hospital facilities for private gain and capitalizing on the hope and hype over stem cell research to promote dubious procedures. Rather than producing biopolitical modes of governance, formal regulation in China often invites enterprising tactics and hybrid practices that ultimately remake the boundaries between public and private, as well as ethical and unethical. © 2011 Taylor & Francis.-
dc.languageeng-
dc.relation.ispartofNew Genetics and Society-
dc.subjectgovernance-
dc.subjectbiopolitics-
dc.subjectChina-
dc.subjectethics-
dc.subjectstem cell science-
dc.titleThe proliferation of stem cell therapies in post-Mao China: Problematizing ethical regulation-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1080/14636778.2011.574375-
dc.identifier.scopuseid_2-s2.0-79958799424-
dc.identifier.volume30-
dc.identifier.issue2-
dc.identifier.spage141-
dc.identifier.epage153-
dc.identifier.eissn1469-9915-
dc.identifier.isiWOS:000291425300002-
dc.identifier.issnl1463-6778-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats